Boston Massachusetts based Aerovate Therapeutics is raising $75,818,727.00 in New Equity Investment.
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Aerovate Therapeutics is raising $75,818,727.00 in new funding. Sources indicate as part of senior management President, Benjamin Dake played a key role…